What Is TB-500?

Molecular Structure and Composition

TB-500 is a synthetic peptide with a 43-residue sequence corresponding to the full-length thymosin beta-4 protein. The peptide carries an N-terminal acetyl modification (Ac-SDKP motif), which distinguishes it from unmodified forms. The molar mass is approximately 4,963 Da. The sequence includes 12 lysine residues, 3 aspartic acid residues, 4 glutamic acid residues, and 1 methionine, contributing charged and polar character throughout the chain. This composition produces a peptide with high net negative charge in physiological solutions.Review · PMID 27450730

Structural characterization through nuclear magnetic resonance (NMR) spectroscopy reveals TB-500 as an intrinsically disordered peptide in solution. The free peptide adopts no single stable conformation but exists in dynamic equilibrium among multiple structures. However, upon binding to actin monomers, the peptide undergoes a disorder-to-order transition, adopting a defined three-dimensional structure. This conformational plasticity—the ability to remain unstructured until binding occurs—is characteristic of the beta-thymosin family of peptides. NMR studies demonstrate that the LKKTET actin-binding segment and the N-terminal region show local helical propensity even in the free state, but the central and C-terminal regions remain highly flexible until actin binding induces global organization.Review · PMID 27450730Review · PMID 17947587

The N-terminal acetylated segment (Ac-SDKP) and the actin-binding domain (LKKTET motif) represent the two principal functional regions of the peptide as determined by structural and mutagenesis studies. NMR analysis under conditions favoring peptide structure shows that both segments maintain some local helical character in solution, though the overall peptide remains largely disordered. The central and C-terminal regions show greater conformational variability.In vitro · PMID 10848969

In-Vitro Binding to Actin Monomers

TB-500 is characterized in biochemical research as an actin-sequestering peptide that binds G-actin (monomeric actin) with micromolar dissociation constants. Biophysical binding assays measure this interaction through surface plasmon resonance, fluorescence spectroscopy, and gel-filtration chromatography in cell-free systems. The peptide forms a 1:1 stoichiometric complex with actin monomers. Binding is rapid and reversible, allowing the peptide to both capture actin monomers and release them on demand. This reversibility is characteristic of the beta-thymosin family and has been confirmed through kinetic measurements of association and dissociation rates using optical biosensor methods.In vitro · PMID 1999398

The binding interaction prevents actin monomer polymerization into filaments (F-actin) in cell-free biochemical systems. Measurement of actin polymerization kinetics in the presence and absence of TB-500 demonstrates significant inhibition of filament assembly. This sequestering activity has been measured through turbidity assays (monitoring light scattering as actin polymerizes), electron microscopy visualization of actin filament formation, and analytical ultracentrifugation tracking monomer-to-polymer transitions. The inhibition of polymerization is stoichiometric—one TB-500 molecule sequesters one actin monomer, preventing it from joining a growing filament.Review · PMID 27450730In vitro · PMID 1999398

Structural studies using X-ray crystallography of TB-500 bound to actin reveal atomic-level detail of the interaction interface. The N-terminal amphipathic helix of TB-500 docks into a binding pocket on the actin surface, with the LKKTET motif anchoring the peptide through electrostatic interactions between positively charged lysine residues and acidic regions of actin. This detailed structural understanding defines how the disordered free peptide adopts an ordered conformation upon actin engagement. The binding interface involves multiple contact points spanning the N-terminal helix and central regions of TB-500.Review · PMID 17947587

In-Vitro Cellular Activity and Biochemical Responses

TB-500 is examined in cultured cell systems through in-vitro cell-based assays measuring cellular responses to the synthetic peptide. Cultured cells exposed to TB-500 are analyzed for changes in cytoskeletal organization, protein localization, and gene expression through microscopy and molecular biology techniques. Fluorescence microscopy following peptide exposure reveals altered patterns of actin filament organization within cells. Immunofluorescence staining tracks the distribution of actin-binding proteins and cellular organelles that depend on cytoskeletal integrity.In vitro · PMID 18306930

In cultured cell studies, TB-500 demonstrates measurable activity in cellular stress responses and survival signaling pathways. Western blotting analysis of cells exposed to the peptide shows changes in phosphorylation of survival-related signaling proteins, including Bcl-2 family proteins and caspase activation in apoptosis assays. Cultured cells exposed to oxidative stress (hydrogen peroxide) show reduced apoptosis markers when pre-exposed to TB-500. These biochemical responses are measured through quantitative PCR of gene expression, protein phosphorylation analysis, and caspase activity assays.Review · PMID 29508629In vitro · PMID 18306930

Additional in-vitro cell-based characterizations examine TB-500 interactions with specific protein partners in cultured cells. Immunoprecipitation experiments identify proteins that directly associate with TB-500 in cell lysates. Yeast two-hybrid screening has identified binding partners of TB-500 in cell-free systems. These molecular interaction studies define the biochemical basis for TB-500's cellular responses in laboratory conditions. Understanding these protein-protein interactions provides mechanistic insight into how TB-500 functions within the cellular environment.Review · PMID 17468232

Analytical and Biochemical Characterization Methods

TB-500 is supplied as a lyophilized (freeze-dried) powder and characterized through standard peptide analytical methods. High-performance liquid chromatography (HPLC) with reversed-phase separation and mass spectrometry detection establishes peptide purity and identity. Amino-acid composition analysis confirms the 43-residue sequence and verifies the presence of the N-terminal acetyl modification. These analytical characterizations are performed as part of routine quality control procedures.Review · PMID 27450730

Mass spectrometry analysis determines the precise molar mass and confirms the intact 43-residue structure. Intact mass spectrometry using electrospray ionization shows the N-acetylated form. Tandem mass spectrometry enables sequencing of the peptide chain through fragmentation patterns. Nuclear magnetic resonance spectroscopy provides conformational information and validates structural assignments made through other methods.Review · PMID 17947587

Stability studies characterize TB-500 degradation under varied conditions using in-vitro biochemical assays. Liquid chromatography-mass spectrometry tracking monitors peptide integrity when exposed to proteolytic enzymes (trypsin, chymotrypsin) in cell-free systems. Thermal stability is assessed by measuring peptide persistence at elevated temperatures and varied pH conditions. These analytical characterizations inform storage specifications and handling procedures for the synthetic peptide. Accelerated degradation studies examining peptide behavior at elevated temperatures provide kinetic information about fragmentation pathways and identify the primary proteolytic cleavage sites. The half-life of TB-500 under various conditions has been determined through such stability assays, establishing the timeframe for peptide persistence in different solution compositions.Review · PMID 27450730

The studies at a glance

Representative in-vitro biochemical characterization of TB-500 and thymosin beta-4

Frequently asked questions